Poster: Clinical Applications

Model-based dose optimisation of intravenous posaconazole for treatment of patients with invasive aspergillosis in the intensive care unit

Thursday 16 October, 2025

Introduction: Posaconazole is a broad-spectrum triazole antifungal drug used for prophylaxis and treatment of invasive fungal infections in critically ill…

Read more

Population pharmacokinetics of vadadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor for treatment of anemia associated with chronic kidney disease

Thursday 16 October, 2025

Objectives: Vadadustat (VADA) is a synthetic, orally bioavailable, small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase enzymes under development for…

Read more

Evaluating the influence of genotype on warfarin dose predictions made using a theory-based PKPD model.

Thursday 16 October, 2025

Objectives:  Warfarin continues to be the mainstay of oral anticoagulation therapy, however, a narrow therapeutic range poses a barrier to…

Read more

Pharmacogenetics-Based Population Pharmacokinetic Analysis for Dosing Optimization of Ritonavir-Boosted Atazanavir in Thai adult HIV-Infected Patients

Thursday 16 October, 2025

Objectives: In Thailand, Ritonavir-Boosted Atazanavir (ATV/RTV) is a preferred protease inhibitor based-regimen for the treatment of HIV infection. The pharmacokinetics…

Read more

Simulation based assessment of different dosing strategies for anti-TNFα monoclonal antibodies in Crohn’s disease patients

Thursday 16 October, 2025

Introduction: Anti-tumour necrosis factor α (TNFα) monoclonal antibodies (mAbs) are a well-established treatment for patients with Crohn’s Disease (CD). However,…

Read more

A multi-model averaging approach improves the performance of model-guided infliximab de-escalation in patients with inflammatory bowel diseases

Thursday 16 October, 2025

Objectives: Underexposure to infliximab is a common cause of loss of response in patients with inflammatory bowel diseases. Dosage regimen escalations…

Read more

Establishing evidence for improved outcomes for HIV+ patients receiving antiretroviral drugs through home delivery

Thursday 16 October, 2025

Objectives: Establishing evidence for interventions that may improve patient care, using data routinely available in electronic healthcare records (EHR), is…

Read more

Model-Informed Precision Dosing of Tacrolimus in Lung Transplantation Early After Surgery Using Model-Predictive Control in the tdmore Framework

Thursday 16 October, 2025

Introduction: Tacrolimus is a critical immunosuppressant drug used in transplantation, but its narrow therapeutic index and highly variable bioavailability make…

Read more

Development of an adaptive dosing approach for doxorubicin in paediatric cancer patients

Thursday 16 October, 2025

Objectives: Anthracyclines, such as doxorubicin, are known for causing potentially irreversible cardiotoxicity. Paediatric cancer patients are at the highest risk…

Read more

Exploring practical limitations of model-based Bayesian dose optimization in intensive care patients

Thursday 16 October, 2025

Introduction Model-based dose adaptation (MBDA) based on empirical Bayes estimates (EBE) plays an important role in optimizing drug treatment in…

Read more